Herold Advisors, Inc. Neurocrine Biosciences Inc Transaction History

Herold Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$75.79 - $100.07 $3,789 - $5,003	-50 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$72.45 - $94.81 $3,622 - $4,740	50 New	50 $4,000
Q4 2021 Jan 20, 2022	SELL	$79.65 - $106.22 $11,947 - $15,933	-150 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$86.18 - $99.03 $12,927 - $14,854	150 New	150 $14,000

626

94M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.